Contact Us

821 Alexander Rd #204
Princeton, NJ 08540
USA
Company Contact
Leeann Essai
NA Head of Marketing
609-683-0700
leeann.essai@guerbet.com
PR Agency Contact
Audrey Wallendal
Comms Manager
Taft Communications
609-683-0700
awallendal@taftcommunica...

More »

Guerbet is a pioneer in the contrast-agent field, with more than 90 years' experience, and is a leader in medical imaging worldwide. It offers a comprehensive range of pharmaceutical products, medical devices and services for diagnostic and interventional imaging, to improve the diagnosis and treatment of patients. With 8% of revenue dedicated to R&D and more than 200 employees distributed amongst its four centers in France, Israel and the United States, Guerbet is a substantial investor in research and innovation. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €807 million in revenue in 2017.

RSNA 2019: Booth #1308

www.guerbet-us.com

News Releases
Nov 25, 2019

Guerbet LLC USA, the U.S. affiliate of the global specialist in contrast media products and comprehensive solutions for medical imaging, will highlight both new and established products in...

Jun 18, 2019

Guerbet LLC USA, the U.S. affiliate of the global specialist in contrast media products and solutions for diagnostic and interventional imaging today announced a group purchasing agreement with...

Nov 26, 2018

Guerbet LLC USA, the U.S. affiliate of the global specialist in contrast media products and comprehensive end-to-end solutions for medical imaging, will highlight new and next-level product...

Nov 21, 2018

Villepinte (France), November 21st, 2018 (8:00 CET) – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, today announced the worldwide launch...

Nov 19, 2018

PRINCETON, N.J., Nov. 19, 2018 -- Guerbet LLC USA (Guerbet), the U.S. affiliate of the global specialist in contrast agents and solutions for medical imaging, will feature its digital solutions...

More »